{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:20:06Z","timestamp":1700457606504},"reference-count":13,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2012]]},"DOI":"10.1536\/ihj.53.199","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T15:05:49Z","timestamp":1340809549000},"page":"199-201","source":"Crossref","is-referenced-by-count":10,"title":["Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient"],"prefix":"10.1536","volume":"53","author":[{"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Shiga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyoko","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 1985; 152: 1182-91.","DOI":"10.1093\/infdis\/152.6.1182"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Valantine HA. The role of viruses in cardiac allograft vasculopathy. Am J Transplant 2004; 4: 169-77. (Review)","DOI":"10.1046\/j.1600-6143.2003.00316.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stehlik J, Edwards LB, Kucheryavaya AY, <i>et al<\/i>. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant 2011; 30: 1078-94.","DOI":"10.1016\/j.healun.2011.08.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cytomegalovirus. Am J Transplant 2004; 4: 51-8. (Review)","DOI":"10.1111\/j.1600-6135.2004.00727.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. W&eacute;clawiak H, Kamar N, Mengelle C, <i>et al<\/i>. Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients. J Med Virol 2008; 80: 1228-32.","DOI":"10.1002\/jmv.21183"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brum S, Nolasco F, Sousa J, <i>et al<\/i>. Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil. Transplant Proc 2008; 40: 752-4.","DOI":"10.1016\/j.transproceed.2008.02.048"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022171"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zuckermann A, Manito N, Epailly E, <i>et al<\/i>. Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung Transplant 2008; 27: 141-9. (Review)","DOI":"10.1016\/j.healun.2007.08.014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Vitko S, Margreiter R, Weimar W, <i>et al<\/i>. Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 2005; 5: 2521-30.","DOI":"10.1111\/j.1600-6143.2005.01063.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tedesco Silva H Jr, Cibrik D, Johnston T, <i>et al<\/i>. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients. Am J Transplant 2010; 10: 1401-13.","DOI":"10.1111\/j.1600-6143.2010.03129.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Vogt PK. PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med 2001; 7: 482-4.","DOI":"10.1016\/S1471-4914(01)02161-X"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Baran DA, Galin ID, Gass AL. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment. Am J Cardiovasc Drugs 2004; 4: 21-9. (Review)","DOI":"10.2165\/00129784-200404010-00003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Gude E, Gullestad L, Arora S, <i>et al<\/i>. Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation. J Heart Lung Transplant 2010; 29: 641-7.","DOI":"10.1016\/j.healun.2010.01.005"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/53\/3\/53_199\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:09:24Z","timestamp":1618816164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/53\/3\/53_199\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.53.199","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}